Pharmaceutical Technology

JUNE 25, 2025

The first tranche will be received by Revolution, following US Food and Drug Administration (FDA) approval of daraxonrasib to treat metastatic PDAC by January 2028. The debt facility portion consists of three tranches totalling up to $750m linked directly to daraxonrasib’s commercial milestones. Sign up for our daily news round-up!

Packaging 52

Packaging Communication Hospitals Insurance 52

Pharmaceutical Technology

JULY 10, 2025

Find out more The transaction will enhance Merck’s cardio-pulmonary pipeline and portfolio with the addition of Ohtuvayre (ensifentrine), an FDA-approved treatment for chronic obstructive pulmonary disease (COPD) in adults. Credit: Merck & Co., Give your business an edge with our leading industry insights.

Packaging 52

Packaging Hospitals Communication FDA 52

Pharmacy Times

JUNE 9, 2025

months versus 2.1 The findings were presented at the 2025 American Society of Clinical Oncology Annual Meeting, which was held in Chicago, Illinois.

Compounding Pharmacies 73

Compounding Pharmacies Immunization Hospitals Compounding 73

Pharmaceutical Technology

JUNE 10, 2025

Without removing the current members, the current Trump administration would not have been able to appoint a majority of new members until 2028, RFK Jr wrote. Mooted for implementation by 30 June, genAI at the FDA has been rolled out ahead of schedule. Can pharma tariffs “Make America Manufacture Again”?

Vaccines 52

Vaccines FDA Immunization Communication 52

The Checkup by Singlecare

AUGUST 29, 2023

Food and Drug Administration (FDA) in 2012 as a brand-name drug. Although a generic was approved in 2019, generic apixaban will not be available on the market until at least April 2028. The FDA approved two applications for generic versions of Eliquis by the companies Micro Labs Limited and Mylan Pharmaceuticals, Inc.

Dosage 52

Dosage Labelling Insurance FDA 52

PharmaShots

JUNE 21, 2023

Shots: The US FDA approved 15 NDAs and 3 BLA in May 2023, leading to treatments for patients and advances in the healthcare industry. with schizophrenia. from various breeds or breed mixes. The drug is only available by prescription from a licensed veterinarian 3.

FDA 40

FDA Hospitals 40

pharmaphorum

SEPTEMBER 13, 2022

During his time working in the pathology museum at Guy’s Hospital in London, Hodgkin studied several preserved specimens of human organs affected by disease. 2001– FDA green lights revolutionary treatments. Today, the bone marrow donor registry comprises more than 39,527,166 donors and 804,246 cord blood units.

Chemotherapy 98

Chemotherapy Immunization FDA Documentation 98